Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PRMT5 | O14744 | 4/20 | 0.53 |
| ▸ | LRRK2 | Q5S007 | 12/20 | 0.49 |
| ▸ | ABCG2 | Q9UNQ0 | 2/20 | 0.42 |
| ▸ | BRD4 | O60885 | 1/20 | 0.42 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.41 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1317015 | 0.90 | PRMT5 (0.55) | PRMT5LRRK2BRD4 | |
| SCHEMBL1318450 | 0.89 | LRRK2 (0.62) | PRMT5LRRK2ABCG2 | |
| SCHEMBL12121423 | 0.86 | KDM4E (0.40) | PRMT5LRRK2ABCG2L3MBTL1 | |
| SCHEMBL27828450 | 0.86 | LRRK2 (0.48) | PRMT5LRRK2BRD4TDP1L3MBTL1 | |
| SCHEMBL1317419 | 0.84 | LRRK2 (0.49) | LRRK2 | |
| SCHEMBL12117497 | 0.82 | ABCG2 (0.44) | ABCG2 | |
| SCHEMBL27847125 | 0.81 | LRRK2 (0.51) | PRMT5LRRK2BRD4TDP1L3MBTL1 | |
| SCHEMBL27989362 | 0.80 | LRRK2 (0.49) | PRMT5LRRK2BRD4 | |
| SCHEMBL27828451 | 0.80 | LRRK2 (0.49) | PRMT5LRRK2BRD4 | |
| SCHEMBL12121553 | 0.79 | PRMT5 (0.43) | PRMT5LRRK2L3MBTL1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8492582-B2 | N-acyl anthranilic acid derivative or salt thereof | TOYAMA CHEMICAL CO., LTD. (JP) | 2013-07-23 | — | — | US | disclosed |
| US-20110275797-A1 | N-ACYL ANTHRANILIC ACID DERIVATIVE OR SALT THEREOF | TOYAMA CHEMICAL CO., LTD. (JP) | 2011-11-10 | — | — | US | disclosed |
| EP-2385036-A1 | N-ACYL ANTHRANILIC ACID DERIVATIVE OR SALT THEREOF | Toyama Chemical Co., Ltd. (JP) | 2011-11-09 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110275797-A1 | N-ACYL ANTHRANILIC ACID DERIVATIVE OR SALT THEREOF | COL14A1, COL2A1, COL1A1 | PRMT5 1535/4885LRRK2 1813/4885ABCG2 4744/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.